Initial Workup for Suspected Lymphoma
The initial workup for suspected lymphoma should include a surgical specimen/excisional lymph node biopsy, comprehensive laboratory studies, and appropriate imaging based on suspected lymphoma type. 1
Biopsy and Pathological Diagnosis
- An excisional lymph node biopsy is mandatory for accurate diagnosis and should be the first step in lymphoma workup 1
- Core biopsies should only be performed when lymph nodes are not easily accessible (e.g., retroperitoneal disease) 1
- Fine needle aspirations are inappropriate for reliable lymphoma diagnosis 1
- Fresh frozen tissue should be stored when possible to allow for additional molecular analyses 1
- The histological report should provide diagnosis according to the World Health Organization (WHO) classification 1
Laboratory Studies
- Complete blood count with platelets and differential 1
- Blood chemistry profile including:
- Disseminated intravascular coagulation (DIC) panel including:
- Tumor lysis syndrome panel including:
- Screening tests for HIV and hepatitis B and C 1
Imaging Studies
- CT scan of neck, thorax, abdomen, and pelvis 1
- PET-CT is not mandatory for all lymphoma types but may be useful to:
- For patients with T-cell lymphoma, chest CT scans are particularly important 1
- For suspected lymphoblastic lymphoma, whole body PET/CT scan is recommended 1
Bone Marrow Assessment
- Bone marrow aspirate and biopsy should be performed in all cases 1
- This helps determine disease extent and involvement of the bone marrow 1
Additional Evaluations Based on Lymphoma Type
For male patients with suspected lymphoma:
For patients with suspected CNS involvement:
For patients with suspected gastrointestinal involvement:
- Gastrointestinal endoscopy may be recommended, especially in limited stage I/II disease 1
Risk Assessment and Staging
- Staging should be performed according to the Ann Arbor classification system 1
- For follicular lymphoma, the Follicular Lymphoma-specific International Prognostic Index (FLIPI) should be determined 1
- For mantle cell lymphoma, assessment of Ki-67 as a histomorphological risk factor is recommended 1
Common Pitfalls to Avoid
- Relying on fine needle aspiration or core biopsies alone for diagnosis, which can miss the heterogeneity of lymphoma 1
- Starting treatment before obtaining adequate tissue for diagnosis 1
- Administering corticosteroids before biopsy, which can mask histologic diagnosis of lymphoma 3
- Overlooking the need for specialized immunohistochemistry (e.g., cyclin D1 for mantle cell lymphoma) 1
- Assuming that routine blood tests alone can detect lymphoma relapse (they have poor sensitivity and positive predictive value) 4
By following this comprehensive diagnostic approach, clinicians can ensure accurate diagnosis and staging of lymphoma, which is essential for determining appropriate treatment strategies and improving patient outcomes.